Scientists hail promise of first effective Ebola treatments in Congo trial
eMediNexus, 13 August 2019
remove_red_eye 602 Views
#Critical Care #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health
Coronavirus Live Count Map India
remove_red_eye 602 Views
Coronavirus Live Count Map World
#Critical Care #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health
Coronavirus FAQ PDF
Scientists are a step closer to finding the first effective treatments for the deadly Ebola hemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo.
Two experimental drugs - Regeneron’s REGN-EB3 and a monoclonal antibody called mAb114 - were both developed using antibodies harvested from survivors of Ebola infection. The treatments are now going to be offered to all patients in the Democratic Republic of Congo (DRC), according to U.S. National Institute of Allergy and Infectious Diseases… (Reuters, August 12, 2019)
To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
.jpg)
Excellent : moving very fast ; Vaccine trail and now a step closer to finding the first effective mAb treatments showing survival rates of as much as 90 percent in the DRC clinical trial.